Live cancer workflows and biomarker discovery.
This page provides a cleaner summary of the broader research direction without exposing internal logic. It highlights live testing, the current biomarker focus, and the broader multi-omics context in a concise, investor-friendly format.
What is happening now
MindNetQ is being applied to complex biomedical problems including cancer biomarker discovery and multi-omics analysis. The current emphasis is live testing, candidate review, and repeatable research validation.
- Live cloud-based cancer workflow testing
- Biomarker and pathway candidate review
- High-level control before downstream use
What this supports
Teams can explore promising signals, review outputs with more confidence, and prepare for later stages of research expansion.
- Clearer candidate prioritization
- Reduced false positives
- More confidence before escalation
Research focus
We are starting with biomarker discovery and validation. After performance is validated through testing, the roadmap expands into broader patient-level analysis and downstream research applications.
Public-safe summary
This page intentionally stays high-level. It avoids deep system details and proprietary mechanics while still communicating the importance of the live research work and the broader commercial direction.